{"id":10490,"date":"2024-02-09T10:46:24","date_gmt":"2024-02-09T08:46:24","guid":{"rendered":"https:\/\/www.alivitpharm.com\/?page_id=10490"},"modified":"2024-02-19T13:24:53","modified_gmt":"2024-02-19T11:24:53","slug":"case-study-hepato-care","status":"publish","type":"page","link":"https:\/\/www.alivitpharm.com\/sr\/case-study-hepato-care\/","title":{"rendered":"Prikaz slu\u010daja: Hepato Care"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Prikaz slu\u010daja: Hepato Care<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Hepato\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Prikaz slu\u010daja 1:<\/span><\/h5>

Mu\u0161karac, MP, starosti 47 godina je pacijent sa istorijom infarkta miokarda. Ima i dislipidemije (povi\u0161ene masno\u0107e u krvi), kao i hipertenziju (povi\u0161en krvni pritisak). Hipertenziju dr\u017ei pod kontrolom sa farmakoterapijom, pije nebivolol u dozi od 2,5mg.<\/p>

Me\u0111utim, uprkos tome \u0161to pije terapiju za povi\u0161en holesterol i trigliceride, ezetimib u dozi od 10mg, te masno\u0107e ne mo\u017ee nikako da dovede u okvir referentnih vrijednosti. Ina\u010de, gospodin je veliki gurman, u\u017eivalac dobre hrane, mada se trudi da u\u017eivanje svede na minimum, jer ima pozitivnu porodi\u010dnu anamnezu kardiovaskularnih oboljenja, otac mu je tako\u0111e obolio od infarkta miokarda.<\/p>

Odlazi kod svog kardiologa na kontrolu, a prije same posjete ljekaru je uradio biohemijske analize, a rezultati tih analiza su sljede\u0107i:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Rezultati biohemijske analize
Glukoza 6.9 mmol\/L
Ukupni Holesterol 5.38 mmol\/L
HDL-Holesterol 1.66 mmol\/L
LDL-Holesterol 3.08 mmol\/L
Trigliceridi 1.41 mmol\/L
S-Aspartat-aminotransferaza (AST) 68 U\/L
S-Alanin-aminotransferaza (ALT) 159 U\/L
S-Alkaline-fosfataza (ALP) 61 U\/L
S-Kreatin-kinaza (CK) 169 U\/L
S-Laktat dehidrogenaza (LDH) 148 U\/L<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Referentne vrednosti :
Glukoza 4,6-6,4 mmol\/L
Ukupni Holesterol manji od 5.20 mmol\/L
HDL-Holesterol M: veci od 1.45 mmol\/L , Z: veci od 1.68mmol\/L
LDL Holesterol, manje od 2.59mmol\/L
Trigliceridi , manje od 1.70 mmol\/L
S-Aspartat-aminotransferaza (AST) M:manje od 40, Z: manje od 30
S-Alanin-aminotransferaza (ALT) M:manje od 41, Z manje od 33
S-Alkaline-fosfataza (ALP) M:40-130 , Z: 35-105
S-Kreatin-kinaza (CK) M:39-308, Z:26-192
S-Laktat dehidrogenaza (LDH) manje od 250<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Podebljanim slovima je ozna\u010deno ono \u0161to je van referentnih vrijednosti, to jest \u0161to je pove\u0107ano, a to su: glukoza nata\u0161te, ukupni holesterol, LDL-holesterol i enzimi (transaminaze) jetre: S-Aspartat-aminotransferaza (AST) i S-Alanin-aminotransferaza (ALT).
Od terapije uzima jo\u0161 acetilsalicilnu kiselinu u dozi od 100mg, uve\u010de, iza obroka.
Zaklju\u010dak bi bio sljede\u0107i:
Postoji jasna korelacija izme\u0111u povi\u0161enog ukupnog holesterola i LDL-holesterola (lo\u0161eg holesterola) i rizika od nastanka aterosklerotskog oboljenja. S obzirom da pacijent ve\u0107 uzima farmakoterapiju i kako ka\u017ee uzima je redovno, svako ve\u010de u isto vrijeme, ljekar se odlu\u010duje da mu ne dodaje u terapiju jo\u0161 jedan lijek nego da poku\u0161a prvo nefarmakolo\u0161kim mjerama da stavi stanje pod kontrolu. Ovakve nalaze pripisuje obilnim obrocima, nedostatku fizi\u010dke aktivnosti, a kako pacijent ka\u017ee u poslednjih pola godine dosta vremena provodi u kafani, te mu se desi da povremeno popije po par alkoholnih pi\u0107a.
Dogovorili su se da uredi svoj \u017eivot, pobolja\u0161a \u017eivotne navike, a zbog povi\u0161enih enzima jetre propisuje mu Black garlic Hepato care proizvod koji sadr\u017ei fermentisani bijeli luk, hajdu\u010dku travu, masla\u010dak, smilje, vitamine B1, B2, B6 i vitamin E, jer kad stavi funkciju jetre pod kontrolu, samim tim \u0107e regulisati i dislipidemiju.
Pacijent je uzimao ovaj proizvod, 3x1 kapsulu iza obroka i nakon dva mjesca redovne primjene, uz svu svoju postoje\u0107u farmakoterapiju, nalazi su bili mnogo bolji.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Rezultati biohemijske analize
Glukoza 6.3 mmol\/L
Ukupni Holesterol 3.47mmol\/L
HDL-Holesterol 1.58mmol\/L
LDL-Holesterol 1.47mmol\/L
Trigliceridi 0.93mmol\/L
S-Aspartat-aminotransferaza (AST) 50 U\/L
S-Alanin-aminotransferaza (ALT) 91U\/L
S-Alkaline-fosfataza (ALP) 59U\/L
S-creatine kinase (CK) 165 U\/L
S-Laktat dehidrogenaza (LDH) 160U\/L<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Referentne vrednosti :
Glukoza 4,6-6,4 mmol\/L
Ukupni Holesterol manji od 5.20 mmol\/L
HDL-Holesterol M: veci od 1.45 mmol\/L , Z: veci od 1.68mmol\/L
LDL Holesterol, manje od 2.59mmol\/L
Trigliceridi , manje od 1.70 mmol\/L
S-Aspartat-aminotransferaza (AST) M:manje od 40, Z: manje od 30
S-Alanin-aminotransferaza (ALT) M:manje od 41, Z manje od 33
S-Alkaline-fosfataza (ALP) M:40-130 , Z: 35-105
S-Kreatin-kinaza (CK) M:39-308, Z:26-192
S-Laktat dehidrogenaza (LDH) manje od 250<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Kao \u0161to mo\u017eete vidjeti iz prilo\u017eenih rezultata, holesterol i trigliceridi su dovedeni u okvir referentnih vrijednosti, a enzimi jetre su jo\u0161 povi\u0161eni, ali manje nego na samom po\u010detku terapije.
Savjetuje se da nastavi sa primjenom Black garlic Hepato care proizvoda, jo\u0161 minimalno 3 mjeseca.
Uz sve ovo ljekar mu savjetuje da uzme i Black garlic Cardio plus preparat, na bazi fermentisanog bijelog luka, bijelog i crvenog gloga i bijele imele, te da svaki dan uzima 3x2 kapsule, nakon obroka, a da lijek ezetimib u dozi od 10mg pije svaku drugu ve\u010de.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Case Study: Hepato Care CASE STUDY 1: A man, MP, aged 47, is a patient with a history of myocardial infarction. He also has dyslipidemia (increased fat in the blood), as well as hypertension (high blood pressure). He keeps his hypertension under control with pharmacotherapy, takes nebivolol in a dose of 2.5 mg. However, despite …<\/p>\n

Prikaz slu\u010daja: Hepato Care<\/span> \u041f\u0440\u043e\u0447\u0438\u0442\u0430\u0458 \u0432\u0438\u0448\u0435 »<\/a><\/p>","protected":false},"author":9,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"class_list":["post-10490","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.alivitpharm.com\/sr\/wp-json\/wp\/v2\/pages\/10490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.alivitpharm.com\/sr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.alivitpharm.com\/sr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.alivitpharm.com\/sr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.alivitpharm.com\/sr\/wp-json\/wp\/v2\/comments?post=10490"}],"version-history":[{"count":0,"href":"https:\/\/www.alivitpharm.com\/sr\/wp-json\/wp\/v2\/pages\/10490\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.alivitpharm.com\/sr\/wp-json\/wp\/v2\/media?parent=10490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}